Yes, Patients Are Getting More Complicated Yes, Patients Are Getting More Complicated
It ' s not your imagination. Those problem lists are getting longer all the time, but the resources to deal with them are shrinking.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 9, 2024 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

Experiencing the Evolution of Early NSCLC Treatment Experiencing the Evolution of Early NSCLC Treatment
Jared Weiss, MD, reflects on his first encounter in training with a patient with early NSCLC and how the treatment landscape has rapidly changed since then.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 8, 2024 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news

Early NSCLC: Three Forms That Contribute to Failure to Diagnose Early NSCLC: Three Forms That Contribute to Failure to Diagnose
Jared Weiss, MD, reflects on the profound impact of patient experiences in which early diagnosis of NSCLC was missed.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 8, 2024 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news

Cannabis for Psychiatric Disorders? Experts Weigh In Cannabis for Psychiatric Disorders? Experts Weigh In
Steve Strakowski, Leslie Hulvershorn, and Christopher Hammond discuss the role of cannabis in psychiatric disorders.Medscape Psychiatry (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 8, 2024 Category: Consumer Health News Tags: Psychiatry Commentary Source Type: news

Targeting IDH Mutated Glioma: A Decade ’s Journey from Bench to Bedside. Targeting IDH Mutated Glioma: A Decade ’s Journey from Bench to Bedside.
Prof Tim Cloughesy reviews the key early development milestones that lead to the evaluation of Vorasidenib in the INDIGO trial.Medscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 8, 2024 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news

Management of IDH-Mutated Gliomas in Germany Management of IDH-Mutated Gliomas in Germany
Learn how expert referral centres optimise treatment for their glioma patientsMedscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 8, 2024 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news

Navigating the Paradigm Shift: A New Era of Glioma Care. Navigating the Paradigm Shift: A New Era of Glioma Care.
Hear Prof Ghazaleh Tabatabai discuss how new clinical data and the application of ‘Personalised Treatment Strategies’ is impacting the care of glioma patients.Medscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 8, 2024 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news

Healthcare Violence: Docs Bear Brunt of Business Pressures Healthcare Violence: Docs Bear Brunt of Business Pressures
Mark A. Lewis, MD, discusses violence in healthcare, including a recent experience with a patient.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 5, 2024 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Do Statins Offset Venous Thrombosis Risk With Hormone Therapy? Do Statins Offset Venous Thrombosis Risk With Hormone Therapy?
Statins might offer a way to reduce the risk for a potentially serious adverse effect of hormone therapy.Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 5, 2024 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

A Snapshot of Ulcerative Colitis: Part I A Snapshot of Ulcerative Colitis: Part I
Watch this patient case study presented by Dr Deborah Fisher for a snapshot of uncontrolled ulcerative colitis and to learn more about what the current guidelines recommend in this situation.Medscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 5, 2024 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news

Changes in the Treatment Landscape of Early-Stage Non-Small Cell Lung Cancer Changes in the Treatment Landscape of Early-Stage Non-Small Cell Lung Cancer
Narjust Florez, MD, reflects on the significant changes in the treatment landscape of early-stage non-small cell lung cancer in recent years.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 5, 2024 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news

Mechanisms of Hypothalamic Inflammation in Obesity Mechanisms of Hypothalamic Inflammation in Obesity
Dr Adam Gilden explores the challenges in managing hypothalamic obesity, and a multidisciplinary approach to address the specific needs of individuals affected by this multifaceted condition.Medscape Diabetes & Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 3, 2024 Category: Consumer Health News Tags: Diabetes & Endocrinology Article Source Type: news

Myelofibrosis Highlights From ASH 2023 Myelofibrosis Highlights From ASH 2023
Key studies on myelofibrosis, presented at ASH 2023, include the phase 3 MANIFEST-2 study, the phase 3 Transform-1 study, and multiple studies on treating anemia in myelofibrosis.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 3, 2024 Category: Consumer Health News Tags: None ReCAP Source Type: news

Clinical Takeaways in Thrombocytopenia From ASH 2023 Clinical Takeaways in Thrombocytopenia From ASH 2023
Clinical takeaways in immune thrombocytopenia (ITP) from ASH 2023 include efficacy of novel therapies, infection risk in chronic ITP, and ITP effects during pregnancy, as reported by Dr Howard Liebman.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 2, 2024 Category: Consumer Health News Tags: Internal Medicine ReCAP Source Type: news

Key Abstracts in HER2-Positive Breast Cancer From SABCS 2023 Key Abstracts in HER2-Positive Breast Cancer From SABCS 2023
Highlights in HER2+ breast cancer from SABCS 2023 include data from the HER2CLIMB-02 trial of tucatinib plus T-DM1 and a 9-year follow-up of the KATHERINE trial, as discussed by Dr Harold Burstein.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 2, 2024 Category: Consumer Health News Tags: None ReCAP Source Type: news